Dr Reddy's (NYSE: RDY) director lists major shareholdings

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD director Satish K Reddy reports his existing equity ownership in a Form 3. He holds 10,107,505 equity shares directly. Indirectly, he is shown with 27,618,385 equity shares via Kallam Satish Reddy HUF and 75,630,620 equity shares via the VSD Family Trust as trustee. This filing records holdings and does not show any new buying or selling activity.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Reddy K Satish

(Last) (First) (Middle)

8-2-337, ROAD NO. #3

(Street)

BANJARA HILLS HYDERABAD 500-034

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Equity Shares	10,107,505	D
Equity shares	27,618,385	I	By Kallam Satish Reddy HUF
Equity shares	75,630,620	I	By VSD Family Trust (as a Trustee)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ SATISH REDDY K	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Satish K Reddy’s Form 3 filing for DR REDDYS LABORATORIES (RDY) show?

The Form 3 filing shows Satish K Reddy’s existing equity ownership in Dr Reddy’s Laboratories. It reports direct and indirect holdings in equity shares, establishing his beneficial ownership position as a company director without indicating any new transactions.

How many DR REDDYS LABORATORIES (RDY) shares does Satish K Reddy hold directly?

Satish K Reddy is reported as directly holding 10,107,505 equity shares of Dr Reddy’s Laboratories. This direct stake reflects shares registered in his own name, separate from additional indirect holdings through entities associated with him.

What indirect DR REDDYS LABORATORIES (RDY) holdings are reported for Satish K Reddy?

The filing lists 27,618,385 equity shares held indirectly through Kallam Satish Reddy HUF and 75,630,620 equity shares held indirectly through the VSD Family Trust, where he is a trustee. These positions supplement his direct share ownership.

Does Satish K Reddy’s Form 3 for RDY indicate any recent share purchases or sales?

No, the Form 3 records holdings only and does not report any recent purchases or sales. Transaction fields show holding entries with unknown transaction codes, indicating this is an initial beneficial ownership report rather than a record of new trading activity.

Why is a Form 3 filed for DR REDDYS LABORATORIES (RDY) director Satish K Reddy?

Form 3 is filed when someone becomes a reporting insider, such as a director, to disclose their beneficial ownership. In this case it details Satish K Reddy’s direct and indirect equity share positions in Dr Reddy’s Laboratories at the time of reporting.